FDA Investigator

Kish Bolden

Latest inspection on record: Lancaster, United States, May 2026 · records back to 2020

Biologics

FDA inspection record · Last updated July 12, 2026

Overview

  • 106 inspections across 84 sites are on record.
  • 19 Form 483 observations are attributed to this investigator.
  • Most recent recorded activity is 2026-05-21.

At a glance

Inspections

106

Sites

84

Observations

19

Career since

Feb 2020

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
Penn Fertility Care - Lancaster General Health21 May 2026Biologics
Serologix, LLC13 May 2026Biologics
Lancaster General Blood Donor Center8 May 2026Biologics
KEDPLASMA LLC16 Apr 2026BiologicsOn file
Safe Guard Biologicals Inc2 Apr 2026Biologics

Sites inspected

Penn Fertility Care - Lancaster General HealthLancaster, United States1 insp.
Serologix, LLCDoylestown, United States1 insp.
Lancaster General Blood Donor CenterLancaster, United States1 insp.
KEDPLASMA LLCCinnaminson, United States1 insp.
Safe Guard Biologicals IncKing Of Prussia, United States1 insp.

Co-investigators

Investigators who share inspections with this person.

Nikisha M Bolden4 shared
Michele Gottshall3 shared
Steven D Banks2 shared
Steen N Graham1 shared
Christopher J Adams1 shared
Cara M Minelli1 shared

Full investigator report

Get the verbatim findings behind Kish Bolden's 19 observations

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site

Related investigators